Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Aclarubicin, Low-Dose Cytarabine Combined With G-CSF (CAG) Regimen For Patients Previously Treated Or Ineligible For Intensive Chemotherapy With Acute Myeloid Leukemia and Myelodysplastic Syndrom: A Single Center Experience

Koichiro Minauchi, MD, Masato Obara, MD, PhD, Takahide Ara, MD, Kanako Shima, MD, Atsushi Yasumoto, MD, PhD, Masanobu Nakata, MD, Shuichi Ota, MD, PhD, Kiyotoshi Imai, MD, Ph.D, Teiichi Hirano, MD, Ph.D, Yoshio Kiyama, MD, Masahiro Ogasawara, MD, PhD, Naoki Kobayashi, MD, PhD, Masahiro Imamura, MD, PhD

Blood (2013) 122 (21): 2697.

https://doi.org/10.1182/blood.V122.21.2697.2697

Published: 2013

Journal Articles

Molecular and Pathological Analysis of DOCK Family Proteins in Hematopoietic Malignancy

Hiroshi Nishihara, MD., PhD., Lei Wang, PhD., Mitsufumi Nishio, MD, PhD, Tomoyuki Endo, MD, PhD, Katsuya Fujimoto, MD, PhD, Masato Obara, MD, PhD, Shinya Tanaka, MD., PhD.

Blood (2011) 118 (21): 5230.

https://doi.org/10.1182/blood.V118.21.5230.5230

Published: 2011

Journal Articles

Both DOCK180 and DOCK2 Participate in the CXCL12 and CCL19 Dependent Chemotaxis of Human Dendritic Cells Derived From Monocytes Through the Activation of Rac

Hideki Goto, MD, PhD, Mitsufumi Nishio, MD, PhD, Katsuya Fujimoto, MD, PhD, Tomoyuki Endo, MD, PhD, Masato Obara, MD, PhD, Keisuke Yamaguchi, MD, PhD, Yukari Takeda, MD, PhD, Hiroshi Nishihara, MD, PhD, Takao Koike, MD, PhD, Masahiro Imamura, MD, PhD

Blood (2011) 118 (21): 521.

https://doi.org/10.1182/blood.V118.21.521.521

Published: 2011

Journal Articles

ROR1 Expression Accelerates Leukemia Development in RORxTCL1 Transgenic Mice,

George F. Widhopf, II, PhD, Bing Cui, Ph.D., Esther Avery, B.S., George Chen, B.S., Masato Obara, MD, PhD, Karen Messer, PhD, Thomas J. Kipps, M.D., Ph.D

Blood (2011) 118 (21): 3905.

https://doi.org/10.1182/blood.V118.21.3905.3905

Published: 2011

Journal Articles

FCGR3A-158V/F Polymorphism May Correlate with the Levels of Immunoglobulin in Patients with Non-Hodgkin’s Lymphoma after Rituximab Treatment as An Adjuvant to Autologous Stem Cell Transplantation.

Mitsufumi Nishio, MD, PhD, Tomoyuki Endo, M.D., Ph.D., Katsuya Fujimoto, M.D., Ph.D., Satoshi Yamamoto, M.D., Ph.D., Masato Obara, M.D., Keisuke Yamaguchi, M.D., Yukari Takeda, M.D., Hideki Goto, M.D., Ikumi Kasahara, M.D., Norihiro Sato, M.D., Ph.D., Takao Koike, M.D., Ph.D.

Blood (2008) 112 (11): 3245.

https://doi.org/10.1182/blood.V112.11.3245.3245

Published: 2008

Journal Articles

Delayed Redistribution of CD27, CD40 and CD80 Positive B Cells and the Impaired In Vitro Immunoglobulin G Production in Patients with Non-Hodgkin Lymphoma Treated with Rituximab.

Mitsufumi Nishio, MD, PhD, Katsuya Fujimoto, MD, PhD, Satoshi Yamamoto, MD, PhD, Toshiya Sakai, MD, Kohki Kumano, MD, Masato Obara, MD, Kazuki Koizumi, MD, PhD, Masaya Mukai, MD, PhD, Norihiro Sato, MD, PhD, Takao Koike, MD, PhD

Blood (2006) 108 (11): 938.

https://doi.org/10.1182/blood.V108.11.938.938

Published: 2006

Journal Articles

Absence of an IgD−/CD27+ Switched Memory B Cell Population with Persistent Hypogammaglobulinemia after Rituximab Administration as an Adjuvant Therapy after Autologous Stem Cell Transplantation for Non-Hodgkin Lymphoma.

Mitsufumi Nishio, MD, PhD, Katsuya Fujimoto, MD, Satoshi Yamamoto, MD, PhD, Toshiya Sakai, MD, Masato Obara, MD, Koki Kumano, MD, Koichiro Minauchi, MD, Masayuki Yamakura, MD, Norihiro Sato, MD, PhD, Takao Koike, MD, PhD

Blood (2005) 106 (11): 1412.

https://doi.org/10.1182/blood.V106.11.1412.1412

Published: 2005

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Aclarubicin, Low-Dose Cytarabine Combined With G-CSF (CAG) Regimen For Patients Previously Treated Or Ineligible For Intensive Chemotherapy With Acute Myeloid Leukemia and Myelodysplastic Syndrom: A Single Center Experience

Molecular and Pathological Analysis of DOCK Family Proteins in Hematopoietic Malignancy

Both DOCK180 and DOCK2 Participate in the CXCL12 and CCL19 Dependent Chemotaxis of Human Dendritic Cells Derived From Monocytes Through the Activation of Rac

ROR1 Expression Accelerates Leukemia Development in RORxTCL1 Transgenic Mice,

FCGR3A-158V/F Polymorphism May Correlate with the Levels of Immunoglobulin in Patients with Non-Hodgkin’s Lymphoma after Rituximab Treatment as An Adjuvant to Autologous Stem Cell Transplantation.

Delayed Redistribution of CD27, CD40 and CD80 Positive B Cells and the Impaired In Vitro Immunoglobulin G Production in Patients with Non-Hodgkin Lymphoma Treated with Rituximab.

Absence of an IgD−/CD27+ Switched Memory B Cell Population with Persistent Hypogammaglobulinemia after Rituximab Administration as an Adjuvant Therapy after Autologous Stem Cell Transplantation for Non-Hodgkin Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Update search

Aclarubicin, Low-Dose Cytarabine Combined With G-CSF (CAG) Regimen For Patients Previously Treated Or Ineligible For Intensive Chemotherapy With Acute Myeloid Leukemia and Myelodysplastic Syndrom: A Single Center Experience

Molecular and Pathological Analysis of DOCK Family Proteins in Hematopoietic Malignancy

Both DOCK180 and DOCK2 Participate in the CXCL12 and CCL19 Dependent Chemotaxis of Human Dendritic Cells Derived From Monocytes Through the Activation of Rac

ROR1 Expression Accelerates Leukemia Development in RORxTCL1 Transgenic Mice,

FCGR3A-158V/F Polymorphism May Correlate with the Levels of Immunoglobulin in Patients with Non-Hodgkin’s Lymphoma after Rituximab Treatment as An Adjuvant to Autologous Stem Cell Transplantation.

Delayed Redistribution of CD27, CD40 and CD80 Positive B Cells and the Impaired In Vitro Immunoglobulin G Production in Patients with Non-Hodgkin Lymphoma Treated with Rituximab.

Absence of an IgD−/CD27+ Switched Memory B Cell Population with Persistent Hypogammaglobulinemia after Rituximab Administration as an Adjuvant Therapy after Autologous Stem Cell Transplantation for Non-Hodgkin Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only